Melphalan, Arsenic Trioxide, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as melphalan, arsenic trioxide, and ascorbic
acid, work in different ways to stop cancer cells from dividing so they stop growing or die.
Arsenic trioxide and ascorbic acid may also help melphalan kill more cancer cells by making
them more sensitive to the drugs.
PURPOSE: This phase II trial is studying how well giving melphalan together with arsenic
trioxide and ascorbic acid works in treating patients with relapsed or refractory multiple
myeloma.